MYC and cancer: To systematically identify the pathways that could enhance MYC inhibitor efficacy, we performed an unbiased genome-wide CRISPR screen in MYC-dependent cancer cells treated with the small-molecule MYC inhibitor MYCi975 (4, 19–21).